Quarterly report · Q1

Period2022-04-01 → 2022-06-30
Filed2022-08-09
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 34
MetricValuePeriodScopeSource row
Revenue¥48.3bn2022-04-01 → 2022-06-30Cons.Net sales
Revenue¥184.8bn2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥46.4bn2021-04-01 → 2021-06-30Cons.Net sales
Operating income¥6.4bn2022-04-01 → 2022-06-30Cons.Operating income
Operating income¥5.9bn2021-04-01 → 2021-06-30Cons.Operating income
Ordinary income¥8.6bn2022-04-01 → 2022-06-30Cons.Ordinary income
Ordinary income¥23.2bn2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥6.3bn2021-04-01 → 2021-06-30Cons.Ordinary income
Profit before tax¥8.5bn2022-04-01 → 2022-06-30Cons.Income before income taxes
Profit before tax¥7.6bn2021-04-01 → 2021-06-30Cons.Income before income taxes
Net income (owners)¥6.0bn2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥17.2bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥5.3bn2021-04-01 → 2021-06-30Cons.Profit loss attributable to owners of parent
Net income¥6.0bn2022-04-01 → 2022-06-30Cons.Profit loss
Net income¥5.3bn2021-04-01 → 2021-06-30Cons.Profit loss
Total assets¥325.4bnat 2022-06-30Cons.Assets
Total assets¥315.5bnat 2022-03-31Cons.Assets
Total assets¥297.8bnat 2021-06-30Cons.Total assets (5-year summary)
Total liabilities¥72.8bnat 2022-06-30Cons.Liabilities
Total liabilities¥69.0bnat 2022-03-31Cons.Liabilities
Net assets / equity¥252.5bnat 2022-06-30Cons.Net assets
Net assets / equity¥246.4bnat 2022-03-31Cons.Net assets
Net assets / equity¥230.8bnat 2021-06-30Cons.Net assets (5-year summary)
Cash and deposits¥46.5bnat 2022-06-30Cons.Cash and deposits
Cash and deposits¥38.5bnat 2022-03-31Cons.Cash and deposits
EPS (basic)¥35.412022-04-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥101.72021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥30.882021-04-01 → 2021-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥35.42022-04-01 → 2022-06-30Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥101.652021-04-01 → 2022-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥30.872021-04-01 → 2021-06-30Cons.Diluted earnings per share (5-year summary)
Equity ratio77.3%at 2022-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio77.8%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio77.2%at 2021-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 52
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-04-01 → 2022-06-30¥2.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-04-01 → 2022-06-30¥2.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-04-01 → 2022-06-30¥27m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-06-30¥473m
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-06-30−¥69m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-06-30−¥69m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-06-30−¥1.9bn
jpcrp040300-q1r_E00836-000Functional Chemicalsreportable segmentrevenue2022-04-01 → 2022-06-30¥21.2bn
jpcrp040300-q1r_E00836-000Functional Chemicalsreportable segmentrevenue external2022-04-01 → 2022-06-30¥21.1bn
jpcrp040300-q1r_E00836-000Functional Chemicalsreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥42m
jpcrp040300-q1r_E00836-000Functional Chemicalsreportable segmentsegment profit2022-04-01 → 2022-06-30¥3.8bn
jpcrp040300-q1r_E00836-000Medicinereportable segmentrevenue2022-04-01 → 2022-06-30¥12.6bn
jpcrp040300-q1r_E00836-000Medicinereportable segmentrevenue external2022-04-01 → 2022-06-30¥12.6bn
jpcrp040300-q1r_E00836-000Medicinereportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥0
jpcrp040300-q1r_E00836-000Medicinereportable segmentsegment profit2022-04-01 → 2022-06-30¥2.4bn
jpcrp040300-q1r_E00836-000Safety Systemsreportable segmentrevenue2022-04-01 → 2022-06-30¥12.4bn
jpcrp040300-q1r_E00836-000Safety Systemsreportable segmentrevenue external2022-04-01 → 2022-06-30¥12.4bn
jpcrp040300-q1r_E00836-000Safety Systemsreportable segmentsegment profit2022-04-01 → 2022-06-30¥1.7bn
—segment totalrevenue2022-04-01 → 2022-06-30¥46.2bn
—segment totalrevenue external2022-04-01 → 2022-06-30¥46.1bn
—segment totalrevenue intersegment2022-04-01 → 2022-06-30¥42m
—segment totalsegment profit2022-04-01 → 2022-06-30¥7.8bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-06-30¥48.4bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-06-30¥48.3bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-06-30¥69m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-06-30¥8.3bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2021-04-01 → 2021-06-30¥2.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2021-04-01 → 2021-06-30¥2.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2021-04-01 → 2021-06-30¥25m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2021-04-01 → 2021-06-30¥444m
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-06-30−¥66m
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2021-06-30−¥66m
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-06-30−¥1.7bn
jpcrp040300-q1r_E00836-000Functional Chemicalsreportable segmentrevenue2021-04-01 → 2021-06-30¥20.1bn
jpcrp040300-q1r_E00836-000Functional Chemicalsreportable segmentrevenue external2021-04-01 → 2021-06-30¥20.1bn
jpcrp040300-q1r_E00836-000Functional Chemicalsreportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥40m
jpcrp040300-q1r_E00836-000Functional Chemicalsreportable segmentsegment profit2021-04-01 → 2021-06-30¥3.4bn
jpcrp040300-q1r_E00836-000Medicinereportable segmentrevenue2021-04-01 → 2021-06-30¥12.8bn
jpcrp040300-q1r_E00836-000Medicinereportable segmentrevenue external2021-04-01 → 2021-06-30¥12.8bn
jpcrp040300-q1r_E00836-000Medicinereportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥0
jpcrp040300-q1r_E00836-000Medicinereportable segmentsegment profit2021-04-01 → 2021-06-30¥1.9bn
jpcrp040300-q1r_E00836-000Safety Systemsreportable segmentrevenue2021-04-01 → 2021-06-30¥11.4bn
jpcrp040300-q1r_E00836-000Safety Systemsreportable segmentrevenue external2021-04-01 → 2021-06-30¥11.4bn
jpcrp040300-q1r_E00836-000Safety Systemsreportable segmentsegment profit2021-04-01 → 2021-06-30¥1.8bn
—segment totalrevenue2021-04-01 → 2021-06-30¥44.3bn
—segment totalrevenue external2021-04-01 → 2021-06-30¥44.2bn
—segment totalrevenue intersegment2021-04-01 → 2021-06-30¥40m
—segment totalsegment profit2021-04-01 → 2021-06-30¥7.1bn
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2021-06-30¥46.5bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2021-06-30¥46.4bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-04-01 → 2021-06-30¥66m
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-06-30¥7.6bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 393
ItemContextValueUnit
Independent auditors report consolidated (text)FilingDateInstantText · Plus
Audit firm1 consolidatedFilingDateInstant
Original text (Japanese)EY新日本有限責任監査法人
Cpa1 audit firm1 consolidatedFilingDateInstant
Original text (Japanese)春  日  淳  志
Cpa2 audit firm1 consolidatedFilingDateInstant
Original text (Japanese)清 水 幹 雄
Number of submissionFilingDateInstant1
Net sales (5-year summary)Prior1YTDDuration46447000000JPY
Net sales (5-year summary)CurrentYTDDuration48296000000JPY
Net sales (5-year summary)Prior1YearDuration184805000000JPY
Ordinary income loss (5-year summary)Prior1YTDDuration6348000000JPY
Ordinary income loss (5-year summary)CurrentYTDDuration8634000000JPY
Ordinary income loss (5-year summary)Prior1YearDuration23154000000JPY
Profit loss attributable to owners of parent (5-year summary)Prior1YTDDuration5265000000JPY
Profit loss attributable to owners of parent (5-year summary)CurrentYTDDuration5957000000JPY
Profit loss attributable to owners of parent (5-year summary)Prior1YearDuration17181000000JPY
Comprehensive income (5-year summary)Prior1YTDDuration5894000000JPY
Comprehensive income (5-year summary)CurrentYTDDuration10334000000JPY
Comprehensive income (5-year summary)Prior1YearDuration26123000000JPY
Net assets (5-year summary)Prior1QuarterInstant230782000000JPY
Net assets (5-year summary)CurrentQuarterInstant252525000000JPY
Net assets (5-year summary)Prior1YearInstant246425000000JPY
Total assets (5-year summary)Prior1QuarterInstant297807000000JPY
Total assets (5-year summary)CurrentQuarterInstant325364000000JPY
Total assets (5-year summary)Prior1YearInstant315459000000JPY
Basic earnings loss per share (5-year summary)Prior1YTDDuration30.88
Basic earnings loss per share (5-year summary)CurrentYTDDuration35.41
Basic earnings loss per share (5-year summary)Prior1YearDuration101.70
Diluted earnings per share (5-year summary)Prior1YTDDuration30.87
Diluted earnings per share (5-year summary)CurrentYTDDuration35.40
Diluted earnings per share (5-year summary)Prior1YearDuration101.65
Equity to asset ratio (5-year summary)Prior1QuarterInstant0.772
Equity to asset ratio (5-year summary)CurrentQuarterInstant0.773
Equity to asset ratio (5-year summary)Prior1YearInstant0.778
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember170503570
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember170503570
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant170503570
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant170503570
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithNoVotingRightsMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember-
Number of voting rights issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember2252000
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesReciprocalHoldingSharesWithFullVotingRightsTreasurySharesEtcMember28000
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember168051100
Number of voting rights issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember1680511
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember172470
Number of shares issued shares voting rightsCurrentQuarterInstant170503570
Number of voting rights issued shares voting rightsCurrentQuarterInstant1680511
Number of shares held in own name treasury shares etcCurrentQuarterInstant_Row1Member2252000
Number of shares held in others names treasury shares etcCurrentQuarterInstant_Row1Member-
Total number of shares held treasury shares etcCurrentQuarterInstant_Row1Member2252000

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-06-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-06-30pass